FDA NDC Directory · JSON-LD · Markdown

HERZUMA

NDC 63459-303 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTRASTUZUMAB
Labeler / ManufacturerCephalon, Inc.
Marketing categoryBiologic License Application · App BLA761091
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRASTUZUMAB (150 mg/7.15mL)
Marketing started20200316
Package count1

External sources

Source: openFDA. Public-domain (CC0).